Summary of Purpose
Closure of Patent Foramen Ovale with the AMPLATZER® PFO OCCLUDER in patients with at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and who have failed conventional therapy.Read More →
The following dates are available for this trial. Trial information last updated on 16 February 2018.
|Unavailable||21 Dec 2007||Unavailable||Unavailable||1 Feb 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|